We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.37B
AUM Growth
+$19.3M
Cap. Flow
-$140M
Cap. Flow %
-2.6%
Top 10 Hldgs %
34.27%
Holding
97
New
8
Increased
22
Reduced
54
Closed
3

Top Sells

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$57.5M
2
ORCL icon
Oracle
ORCL
+$26.5M
3
GEHC icon
GE HealthCare
GEHC
+$15.5M
4
QSR icon
Restaurant Brands International
QSR
+$11.4M
5
SKX
Skechers
SKX
+$8.34M

Sector Composition

Rank Sector Weight
1 Financials 29.93%
2 Communication Services 17.12%
3 Materials 11.29%
4 Energy 10.11%
5 Technology 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAC icon
51
Macerich
MAC
$6.37B
$39.8M 0.74%
3,527,840
+68,000
+2% +$692K
BAC icon
52
Bank of America
BAC
$416B
$39.4M 0.73%
1,374,343
+5,381
+0.4% +$154K
HES
53
DELISTED
Hess
HES
$37.8M 0.7%
277,923
-3,126
-1% -$428K
FDX icon
54
FedEx
FDX
$74B
$37.7M 0.7%
152,225
-770
-0.5% -$176K
CVS icon
55
CVS Health
CVS
$122B
$35.7M 0.66%
516,210
+10,925
+2% +$777K
MRK icon
56
Merck
MRK
$357B
$31.4M 0.59%
272,299
-17,835
-6% -$2.03M
BIIB icon
57
Biogen
BIIB
$32.1B
$31.1M 0.58%
109,185
-6,540
-6% -$1.95M
SPR
58
DELISTED
Spirit AeroSystems
SPR
$30.9M 0.58%
1,057,960
+332,700
+46% +$9.6M
CX icon
59
Cemex
CX
$15.1B
$30.6M 0.57%
4,323,096
-3,400
-0.1% -$21.6K
IVZ icon
60
Invesco
IVZ
$13.9B
$29.2M 0.54%
1,736,838
-7,075
-0.4% -$114K
SAVE
61
DELISTED
Spirit Airlines, Inc.
SAVE
$28.3M 0.53%
1,646,845
+30,325
+2% +$497K
GPK icon
62
Graphic Packaging
GPK
$2.82B
$26M 0.48%
1,082,300
-2,600
-0.2% -$65.3K
DKS icon
63
Dick's Sporting Goods
DKS
$11.6B
$23.2M 0.43%
175,802
-7,250
-4% -$992K
CPA icon
64
Copa Holdings
CPA
$5.2B
$21.6M 0.4%
195,000
OVV icon
65
Ovintiv
OVV
$18.1B
$21.4M 0.4%
562,774
-56,641
-9% -$2.05M
DVN icon
66
Devon Energy
DVN
$54.7B
$19.6M 0.37%
405,765
-1,075
-0.3% -$54K
IBN icon
67
ICICI Bank
IBN
$105B
$18.9M 0.35%
818,950
-2,750
-0.3% -$62.2K
VOD icon
68
Vodafone
VOD
$40.6B
$18.2M 0.34%
1,928,796
-20,708
-1% -$218K
BAP icon
69
Credicorp
BAP
$29.9B
$15.2M 0.28%
103,250
PROF
70
Profound Medical
PROF
$212M
$15M 0.28%
1,168,275
-3,500
-0.3% -$43.4K
FTS icon
71
Fortis
FTS
$27.6B
$9.16M 0.17%
212,403
+21,528
+11% +$938K
XBI icon
72
State Street SPDR S&P Biotech ETF
XBI
$10.6B
$5.85M 0.11%
70,300
-7,200
-9% -$602K
IIF
73
Morgan Stanley India Investment Fund
IIF
$210M
$4.66M 0.09%
+215,000
New +$4.36M
YTRA icon
74
Yatra Online
YTRA
$72.3M
$3.71M 0.07%
1,875,020
-313,000
-14% -$649K
SCHW
75
Charles Schwab
SCHW
$186B
$1.24M 0.02%
21,846

Similar funds

Letko, Brosseau & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Letko, Brosseau & Associates held 97 positions worth $5.37B, up 0.36% from $5.35B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Letko, Brosseau & Associates's Q2 2023 filing shows 8 new, 22 increased, 54 reduced and 3 closed positions. Its largest new stake was Morgan Stanley India Investment Fund: 215,000 shares worth $4.66M. The largest sale was Adient, an estimated $57.5M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q2 2023 buy was Morgan Stanley India Investment Fund: 215,000 shares worth $4.66M.
  • Letko, Brosseau & Associates added most to Pfizer in Q2 2023, an estimated $16.3M increase.
  • Letko, Brosseau & Associates's biggest Q2 2023 reduction was Oracle, cutting an estimated $26.5M.
  • Letko, Brosseau & Associates fully exited Adient in Q2 2023, selling an estimated $57.5M.
  • Letko, Brosseau & Associates's ten largest holdings make up 34% of its $5.37B portfolio in Q2 2023.
  • Letko, Brosseau & Associates opened 8 new positions and closed 3 in Q2 2023.
  • Letko, Brosseau & Associates's portfolio value rose 0.36% quarter-over-quarter to $5.37B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2023, filed 10 Aug 2023.